IMI selects 15 projects for EU and industry funding
This article was originally published in Scrip
Executive Summary
The European Union's Innovative Medicines Initiative (IMI) has selected 15 projects to share €246 million in public and private funding with the aim of bringing innovative medicines to market more quickly.